{"product_id":"ucl-hospitals-injectable-medicines-administration-guide-9781405191920","title":"UCL Hospitals Injectable Medicines Administration","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003eI would definitely recommend this book to all staff with an interest and involvement in intravenous drug therapy.\u003cbr\u003e \u003ci\u003eThe Pharmaceutical Journal\u003cbr\u003e \u003c\/i\u003e\u003cbr\u003e There is no doubt that nurses will find this small book useful. It should be available for consultation in any clinical area where drugs are administered to patients by the injectable routes.\u003cbr\u003e \u003ci\u003eJournal of Clinical Nursing\u003c\/i\u003e\u003cbr\u003e \u003cbr\u003e The safe administration of injectable medicines is key to patient safety. The NPSA recognises the use of injectable medicines is a high risk activity and recommends written information about injectables to be available at the point of preparation.\u003cbr\u003e \u003cbr\u003e The \u003ci\u003eUCL Hospitals Injectable Medicines Administration Guide\u003c\/i\u003e is a practical, accessible guide covering many important aspects of administering medicines by injection. It provides clear, concise information on the preparation and administration of over 245 injectable medicines for adults, paediatrics and neonates. It is\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003e\u003cp\u003eThird edition editorial board viii\u003c\/p\u003e \u003cp\u003eContributors ix\u003c\/p\u003e \u003cp\u003eAcknowledgements x\u003c\/p\u003e \u003cp\u003ePreface xi\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection A 1\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e1 Introduction 1\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e2 Overview 2\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e2.1 Organisation of information in the Guide 2\u003c\/p\u003e \u003cp\u003e2.2 Sources of information and disclaimer 3\u003c\/p\u003e \u003cp\u003e\u003cb\u003e3 UCLH policies 4\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e3.1 Responsibilities of professional staff at UCLH 4\u003c\/p\u003e \u003cp\u003e3.2 Preparation of injectable medicines on wards, clinics and departments at UCLH 5\u003c\/p\u003e \u003cp\u003e\u003cb\u003e4 An overview of intravenous therapy 6\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e4.1 When is intravenous therapy appropriate? 6\u003c\/p\u003e \u003cp\u003e4.2 Drug factors that influence the choice of route 7\u003c\/p\u003e \u003cp\u003e4.3 Disadvantages of intravenous administration 8\u003c\/p\u003e \u003cp\u003e4.4 Routes of intravenous administration 9\u003c\/p\u003e \u003cp\u003e\u003cb\u003e5 Factors affecting patency of intravenous sites 11\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e5.1 Factors increasing failure of intravenous sites 11\u003c\/p\u003e \u003cp\u003e5.2 Factors decreasing failure of intravenous sites 11\u003c\/p\u003e \u003cp\u003e5.3 Occlusion of central venous catheters 11\u003c\/p\u003e \u003cp\u003e\u003cb\u003e6 Methods of intravenous administration 12\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e6.1 Intravenous bolus 12\u003c\/p\u003e \u003cp\u003e6.2 Intermittent intravenous infusion 13\u003c\/p\u003e \u003cp\u003e6.3 Continuous intravenous infusion 13\u003c\/p\u003e \u003cp\u003e6.4 Preparation and administration of intravenous medicines 14\u003c\/p\u003e \u003cp\u003e6.5 Aseptic non-touch technique (ANTT) 15\u003c\/p\u003e \u003cp\u003e\u003cb\u003e7 Extravasation of injectables: overview and management advice 17\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e7.1 Patient factors affecting extravasation 17\u003c\/p\u003e \u003cp\u003e7.2 Medicine factors affecting extravasation 17\u003c\/p\u003e \u003cp\u003e7.3 Administration factors affecting extravasation 21\u003c\/p\u003e \u003cp\u003e7.4 Overall risk for extravasation 21\u003c\/p\u003e \u003cp\u003e7.5 Treatment of extravasation 21\u003c\/p\u003e \u003cp\u003e\u003cb\u003e8 Flushing cannulae, catheters and administration sets 24\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e8.1 Flushing between medicines 24\u003c\/p\u003e \u003cp\u003e8.2 When not to flush 24\u003c\/p\u003e \u003cp\u003e8.3 Flushing catheters and cannulae not in use 25\u003c\/p\u003e \u003cp\u003e8.4 Flushing with heparin 25\u003c\/p\u003e \u003cp\u003e\u003cb\u003e9 Infusion pumps 26\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e9.1 Pumps used at UCLH 26\u003c\/p\u003e \u003cp\u003e9.2 Volumetric pumps 26\u003c\/p\u003e \u003cp\u003e9.3 Syringe pumps 26\u003c\/p\u003e \u003cp\u003e9.4 Pumps for ambulatory use 27\u003c\/p\u003e \u003cp\u003e9.5 Patient-controlled analgesia (PCA) pumps 27\u003c\/p\u003e \u003cp\u003e9.6 Target-controlled anaesthesia (TCI or TIVA) pumps 28\u003c\/p\u003e \u003cp\u003e\u003cb\u003e10 Administration of injectables in primary care 29\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e10.1 Self-caring patients 30\u003c\/p\u003e \u003cp\u003e\u003cb\u003e11 Formulation and presentation of injectables 31\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e11.1 Medicines that require reconstitution 31\u003c\/p\u003e \u003cp\u003e11.2 Preparations in solution requiring further dilution before use 32\u003c\/p\u003e \u003cp\u003e11.3 Preparations available ‘ready to use’ without further dilution 32\u003c\/p\u003e \u003cp\u003e11.4 Preparations available ‘ready to administer’ 32\u003c\/p\u003e \u003cp\u003e\u003cb\u003e12 Pharmaceutical aspects of injectable administration 34\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e12.1 Displacement values 34\u003c\/p\u003e \u003cp\u003e12.2 Sodium content 34\u003c\/p\u003e \u003cp\u003e12.3 Drop size 35\u003c\/p\u003e \u003cp\u003e12.4 Layering 35\u003c\/p\u003e \u003cp\u003e12.5 Fluid restriction 35\u003c\/p\u003e \u003cp\u003e\u003cb\u003e13 Factors influencing medicine stability and compatibility of injectable medicines 37\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e13.1 Degradation 37\u003c\/p\u003e \u003cp\u003e13.2 Precipitation 38\u003c\/p\u003e \u003cp\u003e13.3 Binding of medicines to plastics 38\u003c\/p\u003e \u003cp\u003e13.4 Destabilisation of parenteral emulsions 39\u003c\/p\u003e \u003cp\u003e13.5 Leaching of plasticisers 39\u003c\/p\u003e \u003cp\u003e13.6 Blood and blood products 40\u003c\/p\u003e \u003cp\u003e\u003cb\u003e14 Allergic reactions to injectables 41\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e14.1 Latex allergy 41\u003c\/p\u003e \u003cp\u003e\u003cb\u003e15 Compatibility of drugs in a syringe driver for subcutaneous use 43\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e16 Risk assessment of injectables and risk reduction 45\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e16.1 Risk assessment 45\u003c\/p\u003e \u003cp\u003e16.2 Risk reduction 47\u003c\/p\u003e \u003cp\u003e\u003cb\u003e17 Useful resources 49\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e17.1 Websites 49\u003c\/p\u003e \u003cp\u003e17.2 Further reading 50\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection B 51\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eUser guide 51\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eMonographs in alphabetical order 67\u003c\/p\u003e \u003cp\u003eIndex of monographs 333\u003c\/p\u003e","brand":"John Wiley and Sons Ltd","offers":[{"title":"Default Title","offer_id":49407924601175,"sku":"9781405191920","price":32.25,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9781405191920.jpg?v=1730500975","url":"https:\/\/bookcurl.com\/products\/ucl-hospitals-injectable-medicines-administration-guide-9781405191920","provider":"Book Curl","version":"1.0","type":"link"}